These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27094876)

  • 1. Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA.
    Salgado Júnior W; Donadelli CA; Dos Santos JS; Nonino CB
    Obes Surg; 2016 Nov; 26(11):2718-2723. PubMed ID: 27094876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
    Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
    Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
    Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
    Lalloyer F; Mogilenko DA; Verrijken A; Haas JT; Lamazière A; Kouach M; Descat A; Caron S; Vallez E; Derudas B; Gheeraert C; Baugé E; Despres G; Dirinck E; Tailleux A; Dombrowicz D; Van Gaal L; Eeckhoute J; Lefebvre P; Goossens JF; Francque S; Staels B
    J Hepatol; 2023 Oct; 79(4):898-909. PubMed ID: 37230231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
    Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
    Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
    Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.
    Cazzo E; Jimenez LS; Pareja JC; Chaim EA
    Obes Surg; 2015 Jun; 25(6):982-5. PubMed ID: 25381118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up.
    Norouzian Ostad A; Rajabzadeh F; Jamialahmadi T; Goshayeshi L; Ranjbar G; Rezvani R; Nematy M; Jangjoo A
    Updates Surg; 2023 Apr; 75(3):659-669. PubMed ID: 36529770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass.
    Winder JS; Dudeck BS; Schock S; Lyn-Sue JR; Haluck RS; Rogers AM
    Obes Surg; 2017 Feb; 27(2):376-380. PubMed ID: 27440167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
    Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
    Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal-a Case Series.
    Eilenberg M; Langer FB; Beer A; Trauner M; Prager G; Staufer K
    Obes Surg; 2018 Mar; 28(3):812-819. PubMed ID: 28965313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control.
    Schwenger KJP; Fischer SE; Jackson T; Okrainec A; Allard JP
    Surg Obes Relat Dis; 2018 Sep; 14(9):1233-1239. PubMed ID: 30049593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric Bypass and Influence on Improvement of NAFLD.
    Alli V; Rogers AM
    Curr Gastroenterol Rep; 2017 Jun; 19(6):25. PubMed ID: 28429199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
    Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
    Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
    J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
    BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.